Industry weary of waiving vaccine patents | Business | Economy and finance news from a German perspective | DW | 06.05.2021

Visit the new DW website

Take a look at the beta version of We're not done yet! Your opinion can help us make it better.

  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages


Industry weary of waiving vaccine patents

Sharing excess production and supporting the COVAX program are faster ways to get COVID-19 vaccines to people than removing patent protection, says Nathalie Moll from the European Federation of Pharmaceutical Industries and Associations.

Watch video 03:19